Breaking AI & Tech News Analyzed

In a viral trend on TikTok, Londoners are reviewing upmarket bakeries and cafes in their neighborhoods, sparking conversations about gentrification and the changing face of local businesses.Moses Combe, a 21-year-old from north London, started a series of videos called the 'Endz Department for Research', where he reviews upscale cafes that he wouldn't normally visit. His goal is to investigate the changes happening in his own backyard. Combe's review of Jolene, a bakery he describes as 'giving Gail's Pro Max', comes to £14.20. He enjoys the sausage roll, saying 'They did not skimp out with that sausage, bro.'Combe isn't alone in his reviews. Kobi Coker, a 27-year-old comedian and educator, also reviews 'gentrified' spaces. He says his videos exploring these areas weren't initially intentional but were sparked by noticing new, upmarket establishments opening up on his road during his daily commute. Coker has reviewed the Dusty Knuckle bakery, Jolene, Gail's, and Pret, often joking about his experiences.The trend has led to discussions about gentrification and its impact on local businesses. Coker notes that while some new businesses bring new ideas, the problem is that long-time residents 'aren't necessarily able to participate in it.' Matthew Roberts, operations manager at Jolene, welcomes the attention, saying it's 'all very positive' and that they want to 'welcome absolutely everybody.'Other reviewers, like Daniel Poon, a 27-year-old content creator, review mainstream chains when they release products inspired by other cuisines. He reviewed Pret's ube drink, saying it didn't feel authentic to the original Filipino flavor. Poon appreciates chains' efforts to branch out and try new things, but also values diversity and trying different cuisines.

Peptides are short chains of amino acids that naturally occur in the body, acting as hormones such as insulin, oxytocin and vasopressin, or as fragments released during protein digestion.In recent years, a wave of interest has turned these molecules into purported therapeutic agents for everything from weight loss to anti‑ageing and tissue repair. Prescription drugs like semaglutide (Wegovy) and tirzepatide (Mounjaro) are synthetic peptides that have undergone rigorous clinical testing and are approved for specific medical uses.However, a large portion of the market consists of unregulated, experimental peptides sold for self‑administration. These products often bypass the strict approval processes required for medicines, raising serious safety concerns.Who is using these products? Initially confined to a niche of powerlifters and bodybuilders in the 2010s, the audience has expanded dramatically. Influential figures such as podcaster Joe Rogan have promoted combinations like the “Wolverine stack” (BPC‑157 and TB‑500) for injury recovery, while other compounds—CJC‑1295, MK‑677, ipamorelin, and GHK‑Cu—are marketed for muscle growth and anti‑ageing. Social media platforms are now flooded with instructions on purchasing and injecting these substances.Scientific backing is scant. Reviews of the literature reveal that most experimental peptides have only been tested in animal or cell models. For example, BPC‑157 shows promise for tendon and muscle repair in pre‑clinical studies, but no randomized human trials have validated these effects. Similarly, TB‑4 and its synthetic analogue TB‑500 have demonstrated limited blood‑vessel formation in laboratory settings, yet human data are absent and both are listed as prohibited substances by the World Anti‑Doping Agency.Researchers also highlight a critical knowledge gap: dosage, frequency and treatment duration remain undefined, making self‑administration a gamble.Legal landscape in the UK is clear that peptides not classified as medicines fall outside the Medicines and Healthcare products Regulatory Agency’s (MHRA) remit. If a seller makes medicinal claims, the product must hold a marketing authorisation under the Human Medicines Regulations 2012. The MHRA warns that labeling items as “research use only” does not shield vendors from enforcement when evidence shows the products are intended for human consumption.Health risks are multi‑fold. Experts caution that benefits observed in animal studies do not guarantee safety in humans. Contamination with harmful impurities or bacterial endotoxins can trigger severe reactions, including septic shock. Injecting excess natural peptides may disrupt the body’s tightly regulated hormonal balance, potentially affecting multiple physiological pathways.There is also theoretical concern that augmenting peptide levels could accelerate tumour growth, as some cancers over‑express certain peptide pathways. While no direct cases have been documented, the possibility underscores the need for caution.Additional dangers include improper injection techniques (e.g., air embolism), unknown interactions with existing medications, and the lack of systematic monitoring of long‑term effects. As one researcher put it, “If something goes wrong, users may never notice until irreversible damage has occurred.”

The search for a missing US crew member of a downed F-15E fighter jet entered its second day on Saturday, as Iranian media released pictures of wreckage, including a distinctive F-15 tail fin and a used ejector seat.A pilot was rescued on Friday after the F-15E Strike Eagle became the first US plane to be downed over Iran during the five-week-long war, but the second crew member has not been accounted for.US search and rescue efforts are using low-flying Pave Hawk helicopters and specialist C-130 Hercules transport. Military pilots said the missing crew member would be trying to hide for as long as possible from the Iranian military and potentially seeking to transmit their location relative to a known secret point.Israel extended its war in Lebanon with increased airstrikes, targeting sites in Beirut and Tyre. The Israeli military said it had conducted a wave of strikes on Tehran overnight against what it said were air defence, ballistic missile storage and weapons development facilities.The US president, Donald Trump, said on Friday the episode would not affect efforts to negotiate a peace settlement with Iran. However, he also threatened an unspecified escalation, saying Iran had 48 hours to comply with his demands or face consequences.The conflict has resulted in significant damage and loss of life, with at least 1,900 people killed and 20,000 injured in Iran since the start of the war, according to estimates from the International Federation of Red Cross and Red Crescent societies.

The UK medicines regulator has opened an inquiry into a growing number of clinics that sell injectable peptides while promoting them as cures for everything from ageing to injury recovery. The investigation, disclosed by the Guardian, focuses on whether these businesses are breaching the Human Medicines Regulations 2012 by making unauthorised medicinal claims. Interest in peptide‑based treatments has surged in recent years, driven by social‑media influencers, some healthcare professionals, and direct‑to‑consumer marketers. Yet the scientific foundation for most of these claims is weak, with the bulk of research confined to animal models or cell‑culture studies. According to an MHRA spokesperson, any clinic that advertises a peptide as having therapeutic benefits must treat the product as a medicine, which triggers a comprehensive regulatory framework. "If clinics offering peptide injections make medicinal claims for those treatments, the products will be considered medicines and subject to regulation," the agency warned, adding that it will act against any identified breaches. Guardian reporters identified several high‑ranking Google search results that list peptides such as Cortexin (promoted for neuroprotection), BPC‑157 (claimed to aid tissue repair), and Thymosin Alpha (advertised to boost immunity). After being contacted, one clinic removed the statements from its website. Another clinic, while acknowledging the limited human evidence, continued to market seven specific peptides, providing price lists (£350 per month for a single peptide, £450 for two) and offering delivery via vials, syringes, or pre‑filled pens for an additional fee. During a free consultation, a clinician highlighted the experimental nature of the products, noting the absence of large‑scale, randomised clinical trials and recommending a break of four to eight weeks between treatment cycles to mitigate unknown risks. The clinician suggested BPC‑157 for post‑exercise recovery, describing it as a facilitator of cellular repair and blood flow, but warned against its use in smokers or individuals with a family history of cancer due to potential angiogenic effects. The second peptide discussed was MOTS‑C, portrayed as a mitochondrial enhancer that could improve stress resilience, lower insulin resistance, and reduce visceral fat by boosting cellular energy production (ATP). The MHRA confirmed it is reviewing whether the clinician’s statements constitute medicinal claims. The clinic defended its approach, emphasizing that it clearly informs clients that the peptides are not licensed medicines and that the evidence base is largely pre‑clinical. In a broader statement, Lynda Scammell, head of borderline products at the MHRA, explained that peptide products may be marketed as cosmetics, supplements, or medicines, and each case is assessed on its intended use, pharmacological effect, and supporting evidence. She added, "We disregard claims that products are for ‘research purposes’ if it is clear that such claims are being used as an attempt to avoid medicines regulations." Peptides are short chains of amino acids, some of which occur naturally (e.g., insulin). While synthetic peptide analogues like semaglutide and tirzepatide have secured approval for weight‑loss treatments, many of the compounds promoted by these clinics remain experimental and lack the rigorous safety and efficacy testing required for medicinal products.

Science is often seen as a dry and serious field, but does it have to be? A recent study published in Proceedings of the Royal Society B found that scientists deliver an average of only 1.6 jokes per presentation, with 66% generating only polite chuckles.The findings confirm previous research, including a randomized clinical trial conducted over 20 years ago by Timandra Harkness and Helen Pilcher under the guise of the Comedy Research Project. The study found that laughter levels failed to reach statistical significance, even when scientists attempted to incorporate humor into their talks.However, research suggests that humor can be an effective tool in science communication. A 2025 study called Wit Meets Wisdom found that humor can boost credibility and likability, making researchers seem more trustworthy and their findings less likely to be disputed.Helen Pilcher, a science writer and author, argues that scientists should not be afraid to adopt a more playful tone when communicating their research. By incorporating humor, scientists can build cohesion and foster a sense of shared perspective with their audience.Pilcher suggests that scientists can use humor to make their research more engaging and memorable, without having to convert it into standup comedy. By doing so, scientists can make their research more accessible and enjoyable for a wider audience.

Iran has released footage of US aircraft conducting a search operation for pilots who were shot down in Iranian airspace. The videos, obtained by Iranian authorities, provide a glimpse into the search efforts undertaken by the US military.The release of these videos comes amid heightened tensions between Iran and the United States, with both countries engaging in a delicate diplomatic dance. The incident highlights the complexities of military interactions between nations and the importance of transparency in such situations.

President Donald Trump has unveiled a bold budget request, seeking $1.5 trillion for military spending, a nearly 40% increase from the previous year. This ambitious proposal underscores the White House's priorities, emphasizing military strength and law enforcement.The budget request, while not legally binding, sets the stage for intense congressional negotiations. It includes a proposed $455 billion increase over fiscal year 2026, separate from an emergency request of $200 billion for the US-Israeli conflict with Iran.The plan involves significant shifts in funding, with $73 billion in cuts to domestic programs, including initiatives to counter climate change, boost renewable energy, and support equality and access in housing, education, and healthcare. Instead, funding would be redirected to projects such as Trump's Golden Dome missile defense system, critical minerals investment, US shipbuilding, and troop salary increases.Trump's proposal also emphasizes immigration enforcement, calling for continued funding for the Department of Homeland Security and Immigration and Customs Enforcement to support his mass deportation campaign. The request includes a 13% increase for the Department of Justice, focusing on violent crime.The budget plan faces challenges, including a potential deadlock in Congress over funding for ICE and Customs and Border Patrol. The administration suggests passing the budget through a mechanism known as reconciliation, which could be achieved with a simple majority in Congress.The US military expenditure has steadily increased, reaching $997 billion in 2024, according to the Stockholm International Peace Research Institute. The country consistently spends more on its military than the next nine countries combined, raising questions about priorities in defense and domestic spending.

The conflict between the US and Israel against Iran has taken a devastating toll on the country's healthcare system. At least 2,076 people have been killed and 26,500 wounded in Iran since the US and Israel first launched strikes on the country on February 28.Iranian President Masoud Pezeshkian has strongly condemned the attacks, appealing to international health organizations to respond to the crisis. On Thursday, he wrote on X: “What message does attacking hospitals, pharmaceutical companies and the Pasteur Institute as a medical research center in Iran convey?”The Pasteur Institute, a key center for medical research and vaccine production in Tehran, has been targeted. The institute, founded over 100 years ago in collaboration with the Institut Pasteur in Paris, conducts research on infectious diseases, produces vaccines, and provides advanced diagnostics.According to the World Health Organization (WHO), over 20 attacks on healthcare facilities in Iran have been verified since March 1, resulting in at least nine deaths, including an infectious diseases health worker and a member of the Iranian Red Crescent Society.Some of the facilities hit include:Red Crescent warehouse in Bushehr province, which was destroyed by a drone strike on Friday morning.Tofigh Daru Research and Engineering Company, one of Iran’s largest pharmaceutical companies, which was hit on March 31.Delaram Sina Psychiatric Hospital in Tehran, which was significantly damaged on March 29.Ali Hospital in Andimeshk, which sustained damage from an explosion on March 21.Gandhi Hospital in Tehran, which was damaged during attacks on a nearby television communications tower on March 2.International humanitarian law states that health establishments and units, including hospitals, should not be attacked. The United Nations Security Council resolution 2286 was adopted unanimously in 2016, condemning attacks on healthcare and calling on nations to respect international law.The attacks on healthcare facilities are not limited to Iran. Israel has also targeted healthcare facilities in Lebanon and Gaza, resulting in significant damage and loss of life.

Iranian military units have launched a coordinated search for the two pilots of a United States F‑15 fighter jet that was struck by an Iranian air‑defence system over the country's southwest region. The operation, reported by the state‑run Fars news agency, is the first documented crew‑recovery effort since the US‑Israeli war with Iran began on 28 February. State media released images showing the aircraft's wreckage, including an ejection seat attached to a parachute, underscoring the seriousness of the incident. Reuters cited two U.S. officials confirming that a fighter jet was downed and that a search‑and‑rescue mission is underway for any survivors. Iranian Parliament Speaker Mohammad‑Bagher Ghalibaf used the event to mock President Donald Trump’s repeated claims of victory, posting on social media that the conflict had been reduced from "regime change" to a plea for the location of the pilots. According to Iranian reports, the downed aircraft was an F‑15 likely crewed by two pilots. The Pentagon and U.S. Central Command (CENTCOM) have not issued an immediate comment, a pattern consistent with past Iranian claims that CENTCOM swiftly denied. Local Iranian television broadcast footage of the jet's debris, and officials appealed to civilians to remain vigilant for any survivors. The governor of Kohgiluyeh and Boyer‑Ahmad province announced that anyone who captures the crew would receive special commendation, as relayed by the semi‑official ISNA news agency. U.S. lawmakers responded with statements of support. Senate Minority Leader Chuck Schumer posted on X, "I’m praying for the safe return of the crew aboard the fighter jet and all of those working to rescue them in these dangerous conditions." Since the war's onset, the United States has reported the loss of three F‑15s in a friendly‑fire incident over Kuwait and a refuelling aircraft that crashed in Iraq, killing six crew members. Iran, meanwhile, claims to have downed dozens of U.S. drones and continues to assert that its new air‑defence system, introduced after the 12‑day war, remains operational. While President Trump and his advisers repeatedly assert that the United States has neutralised Iran’s air‑defences, the downing of the jet and the ensuing search highlight the ongoing volatility of the conflict.